Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Trauner, M; Arrese, M; Wagner, M.
Fatty liver and lipotoxicity.
Biochim Biophys Acta. 2010; 1801(3): 299-310. Doi: 10.1016/j.bbalip.2009.10.007 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Führende Autor*innen der Med Uni Graz
Trauner Michael
Co-Autor*innen der Med Uni Graz
Wagner Martin
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Fatty liver disease comprises a spectrum ranging from simple steatosis to steatohepatitis which can progress to liver cirrhosis and hepatocellular cancer. Hepatic lipotoxicity may ensue when the hepatic capacity to utilize, store and export fatty acids (FA) as triglycerides is overwhelmed. Additional mechanisms of hepatic lipotoxicity include abnormal FA oxidation with formation of reactive oxygen species, disturbances in cellular membrane FA and phospholipid composition, alterations of cholesterol content and ceramide signalling. Lipotoxicity is a key factor for the progression of fatty liver disease by inducing hepatocellular death, activating Kupffer cells and an inflammatory response, impairing hepatic insulin signalling resulting in insulin resistance, and activation of a fibrogenic response in hepatic stellate cells that can ultimately lead to cirrhosis. Therefore, the concept of hepatic lipotoxicity should be considered in future therapeutic concepts for fatty liver disease.
Find related publications in this database (using NLM MeSH Indexing)
Animals -
Disease Progression -
Fatty Acids - metabolism
Fatty Liver - metabolism
Humans -
Insulin Resistance -
Liver Neoplasms - metabolism
Models, Biological -

Find related publications in this database (Keywords)
Non-alcoholic fatty liver disease
Steatohepatitis
Lipotoxicity
Fatty acid
© Med Uni Graz • Impressum